Literature DB >> 24366650

Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features.

Marina de Tommaso1, Maria Nolano, Florenzo Iannone, Eleonora Vecchio, Katia Ricci, Marta Lorenzo, Marianna Delussi, Francesco Girolamo, Vito Lavolpe, Vincenzo Provitera, Annamaria Stancanelli, Giovanni Lapadula, Paolo Livrea.   

Abstract

In fibromyalgia (FM), reduced habituation of laser-evoked potentials (LEPs) suggests a dysfunction of pain processing at a central level. In this study, we aimed to further examine the nociceptive pathways at the peripheral to the central level in a large group of FM patients by means of LEPs and skin biopsy, in light of healthy controls findings and main clinical features. One hundred and ninety-nine FM patients and 109 age- and sex-matched controls were submitted to LEPs by the dorsum of the right hand and the skin over the right chest and knee tender point stimulation. Skin biopsy was performed in 21 randomly selected FM patients and 60 age- and sex-matched controls. The mean N2-P2 amplitude was reduced in the whole FM group, with normal or even increased values in patients with migraine as comorbidity and reduced values in other patients including those presenting with distal sensory deficits. All patients had reduced N2-P2 habituation in respect to controls. In the FM group, LEPs habituation was correlated with pain at tender points and bad quality of life. Epidermal fiber density was significantly reduced in FM patients versus controls, and correlated with N2-P2 amplitude by the hand and chest tender-point stimulation. Dysfunction in the nociceptive system at both the central and peripheral levels may concur to explain phenotypical eterogeneity and clinical symptom complexity in fibromyalgia.

Entities:  

Mesh:

Year:  2013        PMID: 24366650     DOI: 10.1007/s00415-013-7211-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

Review 1.  Clinical usefulness of laser-evoked potentials.

Authors:  Rolf-Detlef Treede; Jürgen Lorenz; Ulf Baumgärtner
Journal:  Neurophysiol Clin       Date:  2003-12       Impact factor: 3.734

2.  Scalp topography and dipolar source modelling of potentials evoked by CO2 laser stimulation of the hand.

Authors:  M Valeriani; L Rambaud; F Mauguière
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1996-07

Review 3.  Habituation and migraine.

Authors:  Gianluca Coppola; Francesco Pierelli; Jean Schoenen
Journal:  Neurobiol Learn Mem       Date:  2008-08-26       Impact factor: 2.877

4.  A comparative study of cortical responses evoked by transcutaneous electrical vs CO(2) laser stimulation.

Authors:  Marina de Tommaso; Roberto Santostasi; Vito Devitofrancesco; Giovanni Franco; Eleonora Vecchio; Marianna Delussi; Paolo Livrea; Zaza Katzarava
Journal:  Clin Neurophysiol       Date:  2011-06-08       Impact factor: 3.708

Review 5.  Peripheral pain mechanisms in chronic widespread pain.

Authors:  Roland Staud
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-04       Impact factor: 4.098

6.  Fibromyalgia comorbidity in primary headaches.

Authors:  M de Tommaso; M Sardaro; C Serpino; F Costantini; E Vecchio; M Pia Prudenzano; P Lamberti; P Livrea
Journal:  Cephalalgia       Date:  2009-12-15       Impact factor: 6.292

7.  Small fibre pathology in patients with fibromyalgia syndrome.

Authors:  Nurcan Üçeyler; Daniel Zeller; Ann-Kathrin Kahn; Susanne Kewenig; Sarah Kittel-Schneider; Annina Schmid; Jordi Casanova-Molla; Karlheinz Reiners; Claudia Sommer
Journal:  Brain       Date:  2013-03-09       Impact factor: 13.501

8.  Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome.

Authors:  S J Gibson; G O Littlejohn; M M Gorman; R D Helme; G Granges
Journal:  Pain       Date:  1994-08       Impact factor: 6.961

9.  Sodium channel blockers and axonal protection in neuroinflammatory disease.

Authors:  Stephen G Waxman
Journal:  Brain       Date:  2005-01       Impact factor: 13.501

Review 10.  Classification, epidemiology, and natural history of fibromyalgia.

Authors:  K P White; M Harth
Journal:  Curr Pain Headache Rep       Date:  2001-08
View more
  19 in total

Review 1.  [Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups].

Authors:  N Üçeyler; M Burgmer; E Friedel; W Greiner; F Petzke; M Sarholz; M Schiltenwolf; A Winkelmann; C Sommer; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

2.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

Review 3.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

Review 4.  Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome.

Authors:  Geoffrey Littlejohn
Journal:  Nat Rev Rheumatol       Date:  2015-08-04       Impact factor: 20.543

Review 5.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

6.  Sleep features and central sensitization symptoms in primary headache patients.

Authors:  Marina de Tommaso; Marianna Delussi; Eleonora Vecchio; Vittorio Sciruicchio; Sara Invitto; Paolo Livrea
Journal:  J Headache Pain       Date:  2014-09-26       Impact factor: 7.277

7.  Skin cytokine expression in patients with fibromyalgia syndrome is not different from controls.

Authors:  Nurcan Üçeyler; Susanne Kewenig; Waldemar Kafke; Sarah Kittel-Schneider; Claudia Sommer
Journal:  BMC Neurol       Date:  2014-09-22       Impact factor: 2.474

8.  Neuropathic pain as part of chronic widespread pain: environmental and genetic influences.

Authors:  Sukhleen K Momi; Stella Maris Fabiane; Genevieve Lachance; Gregory Livshits; Frances M K Williams
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

9.  Reduced intraepidermal nerve fiber density after a sustained increase in insular glutamate: a proof-of-concept study examining the pathogenesis of small fiber pathology in fibromyalgia.

Authors:  Steven E Harte; Daniel J Clauw; John M Hayes; Eva L Feldman; Irene C St Charles; Christopher J Watson
Journal:  Pain Rep       Date:  2017-04-15

10.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.